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Summary
Objective: To identify factors associated with change in femoral cartilage volume over 2 years in a cohort largely without knee radiographic
osteoarthritis.
Methods: A total of 252 subjects (mean 45 years, range 28e60) were used for this study. T1-weighted fat saturation magnetic resonance
imaging was performed at baseline andw2 years later. Knee femoral condyle cartilage volume, femoral cartilage defect (0e4 scale) and tibial
bone size were determined.
Results: The total femoral cartilage volume loss was 6.3% for the 2.3-year period. Factors associated with this annual change were female
gender (females vs males: 1.69%, P< 0.01), age (over vs under 40 years: 0.96%, P¼ 0.01), smoking (b: 0.04% per pack-years,
P< 0.01), as well as lower limb muscle strength (r: þ0.32, P< 0.01) and its change (b: þ0.34% per quartile, P< 0.05). Structural factors
associated with change included baseline femoral cartilage volume (b: 0.36% per ml, P< 0.01), femoral cartilage defects (b: þ1.07% per
grade, P< 0.01), tibial bone area (b: þ0.13% per cm2, P< 0.05), lateral osteophytes (b: 1.91% per grade, P< 0.01) and change in femoral
cartilage defects (b: 0.8% per grade, P< 0.001).
Conclusions: This study provides evidence conﬁrming that signiﬁcant risk factors are associated with femoral cartilage loss and these include
gender (female), age, smoking, and severity of lower limb muscle weakness. It also supports the hypothesis that femoral cartilage swelling
reﬂected by an increased baseline cartilage volume could be a predictor of disease progression. Our ﬁndings also provide interesting clues
to implement preventive measures that can possibly prevent or reduce knee cartilage loss.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Femoral cartilage loss, Risk factor, Bone area, Cartilage defect, Osteoarthritis.Introduction
Knee osteoarthritis (OA) is a common chronic disease
characterised by loss of knee articular cartilage. There has
been increasing interest in the use of magnetic resonance
imaging (MRI) in the measurement of knee cartilage volume
as a possible outcome measure in knee OA1e3. Tibial carti-
lage volume measurement is valid, accurate and reproduc-
ible1,2,4 and has been associated in certain studies of early
OA with joint space narrowing assessed in radiographs5,6.
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443over time has been associated with age7e9, female sex7,9,
body mass index (BMI)9, genetics10, smoking11, weaker
limb muscle strength12, baseline knee cartilage defects13,14,
change in cartilage defects13 and baseline cartilage vol-
ume8,9 in healthy subjects and/or patients with OA. Femoral
cartilage, which articulates with three knee compartments
(the medial and lateral tibiofemoral compartments and the
patellofemoral compartment), is also an important compo-
nent of knee structural change in healthy15,16 and OA3,17
subjects, and correlation has been reported between femoral
and tibial cartilage volume and change in tibial cartilage vol-
ume, respectively17,18. Furthermore, femoral cartilage vol-
ume was associated with joint space width18,19 but change
in total knee cartilage volume as well as medial and lateral
compartments were not associated with change in joint
space narrowing3,9 in OA subjects. However, so far, very
few reports have examined the factors associated with
change in femoral cartilage volume.
The aim of this longitudinal MRI based study was to eval-
uate factors associated with change in femoral cartilage
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years.Materials and methodsSUBJECTSThe study was carried out in Southern Tasmania, and primarily in the
capital city of Hobart, from June 2000 until December 2001. The follow-up
study was conducted approximately 2 years later (mean 2.3 years; range
1.8e2.6 years). Subjects were selected from two sources. Some subjects
were the adult children (offspring, n¼ 110, mean age: 45, females: 58%)
of subjects who had a knee replacement performed for primary knee OA
at any Hobart hospital in the years 1996e2000. This diagnosis was
conﬁrmed by reference to the medical records of the orthopaedic surgeon
and the original radiograph where possible. Others were controls (n¼ 142,
mean age: 45, females: 57%) selected at random from the state Electoral
Roll. Subjects from either group were excluded on the basis of contraindica-
tion to MRI (including metal sutures, presence of shrapnel, iron ﬁlings in the
eye and claustrophobia). This study was approved by the Southern Tasma-
nian Health and Medical Human Research Ethics Committee and all subjects
provided informed written consent.ANTHROPOMETRICSTable I
Characteristics of participants
Males
(N¼ 107)
Females
(N¼ 145)
Baseline variablesWeight and height were measured, and BMI (kg/m2) was calculated.
Objective measures of physical activity included measurement of muscle
strength by dynamometry at the lower limb (involving both legs simulta-
neously)2,20 at baseline and follow-up. The muscles measured with this tech-
nique were mainly the quadriceps and hip ﬂexors. Subjects were instructed
in each technique prior to testing and each measurement was performed
twice. Repeatability estimates (Cronbach’s a) were 0.91. The devices were
calibrated by suspending known weights at regular intervals2,20. Change
in lower limb muscle strength was calculated as: follow-up muscle
strength baseline muscle strength, and annual percentage change in
lower limb muscle strength was calculated as: 100((follow-up muscle
strength baseline muscle strength)/baseline muscle strength)/time be-
tween two visits in years.Age (years) 45.0 (6.9) 44.9 (6.5)
Height (cm) 176.1 (6.4) 164.1 (5.6)**
Weight (kg) 84.2 (12.9) 71.6 (14.3)**
2
SMOKING, KNEE PAIN AND PAST KNEE INJURYBMI (kg/m ) 27.5 (3.7) 26.7 (5.1)
Lower limb muscle strength (kg) 172.0 (34.3) 95.0 (22.0)**
Ever smoking (%) 47 46
Pack-years of smoking 8.0 (12.4) 6.4 (11.2)
Knee pain (%) 36 27
Knee mechanical angle (() 178.3 (1.9) 178.1 (1.8)
Past knee injury (%) 31 13**
ROA (%) 13 17
Medial joint space
narrowing (%)
8 17
Medial osteophytes (%) 9 4
Lateral joint space 1 5Smoking status (no smoking, former smoking and current smoking) and
years of smoking duration were determined from the following questions:
‘‘Have you ever smoked cigarettes on a regular basis?’’ ‘‘If yes, at what
age did you start smoking regularly?’’ ‘‘Do you currently smoke cigarettes?’’
and ‘‘If you have given up smoking, at what age were you when you gave
up?’’ Then cigarette number each day was recorded for current and former
smokers. The total cigarette number (pack-years) was calculated as: (smok-
ing years cigarette number each day)/20.
Knee pain at baseline was assessed by questionnaire and was deﬁned as
pain for >24 h in the last 12 months or daily pain in more than 30 days of the
last year10. Our deﬁnition of past knee injury was documented by question-
naire as ‘‘Have you had a previous knee injury requiring non-weight bearing
treatment for more than 24 h or surgery?’’21.narrowing (%)
Lateral osteophytes (%) 6 1
Medial femoral cartilage
volume (ml)
5.5 (1.2) 3.9 (0.8)**RADIOGRAPHIC OSTEOARTHRITIS (ROA) AND KNEE
ALIGNMENTLateral femoral cartilage
volume (ml)
5.8 (1.1) 4.0 (0.8)**
Total femoral cartilage
volume (ml)
11.2 (2.1) 7.9 (1.4)**
Medial femoral cartilage defects 1.00 (0.47) 0.88 (0.46)*
Lateral femoral cartilage defects 0.97 (0.43) 0.79 (0.48)**
Medial tibial bone area (cm2) 19.8 (2.1) 15.7 (1.5)**A standing anteroposterior semiﬂexed view of the right knee was per-
formed in all subjects at baseline and scored individually for osteophytes
and joint space narrowing as previously described5.
Knee angle was measured on the knee radiography as described
before22. The anatomic angle was converted to mechanical-axis angle:
mechanical angle¼ 0.69 anatomic angleþ 53.69. An angle less than
178.5 was deﬁned as varus while greater than 180 was deﬁned as valgus.Lateral tibial bone area (cm2) 13.7 (1.7) 10.8 (1.2)**
Change during 2.3-year follow-up
Medial femoral cartilage (ml) 0.36 (0.28) 0.32 (0.26)KNEE FEMORAL CONDYLE CARTILAGE VOLUME
MEASUREMENT
Lateral femoral cartilage (ml) 0.36 (0.24) 0.32 (0.28)
Medial femoral cartilage (%) 6.4 (4.6) 7.8 (5.9)
Lateral femoral cartilage (%) 6.3 (3.9) 7.7 (5.8)*
Total femoral cartilage (%) 6.3 (3.9) 7.8 (5.8)*
Medial femoral cartilage defects þ0.06 (0.62) 0.11 (0.70)
Lateral femoral cartilage defects 0.03 (0.51) 0.17 (0.67)
Mean (SD) except for percentages for ever smoking and
ROA. *P< 0.05, **P< 0.01 for t test between male and female.MRI scans of the right knees were performed at baseline and follow-up.
Knees were imaged in the sagittal plane on a 1.5-T whole body magnetic
resonance unit (Picker, Cleveland, OH, USA) with use of a commercial
transmitereceive extremity coil and a T1-weighted fat saturation three-
dimensional (3D) gradient recall acquisition2,16. Knee femoral cartilage
volume was determined by means of image processing on an independent
workstation using Cartiscope (ArthroVision Inc., Montreal, Quebec,
Canada) running on a Windows NT/9x workstation, as previously
described3,4,9,23. The segmentation of the cartilageesynovial interfaceswas then carried out, with the semi-automatic method under reader supervi-
sion and with corrections when needed. Cartilage volume was evaluated di-
rectly from a standardised view of 3D cartilage geometry as the sum of
elementary volumes. The coefﬁcient of variation (CV) was about 2%3. The
cartilage volume assessment was done for the entire femoral condyle and
the medial and lateral condyles were also delineated by the Blumensaat’s
line and include the trochlear area4. Rates of change in femoral cartilage
volume were calculated as: percentage change per annum¼ [100((follow-
up cartilage volume baseline cartilage volume)/baseline cartilage
volume)/time between two scans in years].KNEE FEMORAL CARTILAGE DEFECT ASSESSMENTThe cartilage defects (0e4 scale) were graded at medial femoral and lat-
eral femoral sites as previously described, with excellent reproducibility16:
grade 0, normal cartilage; grade 1, focal blistering and intracartilaginous
low-signal intensity area with an intact surface and bottom; grade 2, irregu-
larities on the surface or bottom and loss of thickness of less than 50%;
grade 3, deep ulceration with loss of thickness of more than 50%; grade 4,
full-thickness chondral wear with exposure of subchondral bone. Changes
in femoral cartilage defects were calculated by subtracting femoral cartilage
defect scores at baseline from those at follow-up, for the change in femoral
cartilage defect score is linear in its association with the change in femoral
cartilage volume.KNEE BONE SIZE MEASUREMENTKnee tibial plateau bone area was determined by means of image pro-
cessing on an independent workstation using Osiris as previously
445Osteoarthritis and Cartilage Vol. 16, No. 4described2,16. To transform the images to the axial plane, the Analyse Soft-
ware package developed by the Mayo Clinic was employed. The CVs for
these measures were 2.2e2.6%2. Femoral surface bone area was not deter-
mined as no speciﬁc tool yet exists for this measurement.DATA ANALYSISUnivariable and multivariable linear regression analyses were used to ex-
amine the associations between annual percentage change in femoral carti-
lage volume, and age, sex, BMI, smoking, lower limb muscle strength (as
both a continuous variable or categorised by quartiles), baseline femoral car-
tilage volume and defect score, tibial bone area, ROA, percentage change in
muscle strength (as a continuous variable or categorised by quartiles) and
change in femoral cartilage defect score. Standard diagnostic checks of
model ﬁt and residuals were routinely made, and data points with large resid-
uals and/or high inﬂuence were investigated for data errors.
To describe the association between change in cartilage volume and
change in cartilage defect, baseline lower limb muscle strength or quartiles
of change in muscle strength after adjustment for important covariates, the
end results were manipulated as described13: residuals from the regression
of change in femoral cartilage volume, change in femoral cartilage defects, or
baseline lower limb muscle strength on age, sex, BMI, OA family history,
muscle strength baseline femoral cartilage volume, and/or ROA represent
the component of cartilage volume change, cartilage defect change, or base-
line lower limb muscle strength not explained by these factors. We added
these residuals to the mean values, and plotted the ‘‘adjusted’’ cartilage vol-
ume change against ‘‘adjusted’’ cartilage defect change, or ‘‘adjusted’’ lower
limb muscle strength. A P-value less than 0.05 (two-tailed) or a 95% conﬁ-
dence interval (CI) not including the null point was regarded as statistically
signiﬁcant. All statistical analyses were performed on SPSS version 12.0
for Windows (Chicago, IL, USA).Results
A total of 325 subjects (58% female) aged between 28
and 60 (mean 45 years) completed the study. The average
time between the visits was about 2 years. The original re-
sponse rate (second visit) was 87%. In order to have a reli-
able reading, we analysed only those with high image
quality. Thus, the femoral cartilage volume was measuredTable I
Factors associated with annual chan
Univariable
Medial femoral cartilage volume change
Gender (female vs male) 0.59 (1.26, þ0
Age (per year) L0.05 (L0.10, L
Age 40 (>40 years vs <40 years) L1.09 (L1.88, L
BMI (per kg/m2) þ0.02 (0.05, þ0
Ever smoking (current and former vs not) 0.60 (1.27, þ0
Years of smoking (per year) L0.04 (L0.07, L
Pack-years of smoking (per pack-years) L0.04 (L0.07, L
Lateral femoral cartilage volume change
Gender (female vs male) 0.61 (1.25, þ0
Age (per year) 0.05 (0.09, þ0
Age 40 (>40 years vs <40 years) L0.94 (L1.70, L
BMI (per kg/m2) þ0.02 (0.05, þ0
Ever smoking (current and former vs not) 0.29 (0.92, þ0
Years of smoking (per year) L0.03 (L0.06, L
Pack-years of smoking (per pack-years) L0.03 (L0.06, L
Total femoral cartilage volume change
Gender (female vs male) L0.63 (L1.25, L
Age (per year) L0.05 (L0.10, L
Age 40 (>40 years vs <40 years) L1.02 (L1.75, L
BMI (per kg/m2) þ0.02 (0.05, þ0
Ever smoking (current and former vs not) 0.46 (1.07, þ0
Years of smoking (per year) L0.04 (L0.06, L
Pack-years of smoking (per pack-years) L0.04 (L0.06, L
Bold denotes statistically signiﬁcant result.
*Adjusted for baseline cartilage volume, ROA and OA family history, anfor 252 subjects or 78%. There were no signiﬁcant differ-
ences in demographic or structural factors between the
whole cohort and the subjects who were not included
(data not shown). In addition, there were no statistically sig-
niﬁcant differences in the magnitude of these associations
between the offspring and control group and thus these
groups were combined for all the analyses. Characteristics
of the subjects are presented in Table I. The overall knee
femoral cartilage volume decreased on average by
0.72 ml or 6.3% (P< 0.001) during this period. There
were no differences in annual loss of total femoral cartilage
volume between offspring and controls (3.2% for offspring
vs 3.4% for controls, P¼ 0.49) and between subjects with
(n¼ 213) and without (n¼ 39) ROA at baseline (both
3.3%, P¼ 0.86). Associations were similar on both those
with and without ROA so the two groups were combined.
Over 2.3 years, females had greater loss of total femoral
cartilage volume than males (P¼ 0.045).
In multivariable analysis, females had a signiﬁcantly higher
rate of loss of medial, lateral and total femoral cartilage volume
(Table II), but these sex differences became non-signiﬁcant
after further adjustment for lower limbmuscle strength (medial:
0.31%, P¼ 0.43; lateral: 0.31%, P¼ 0.58 and total:
0.41%, P¼ 0.46). Age as a continuous variable was signiﬁ-
cantly associated with loss of lateral and total but not medial
femoral cartilage volume. In contrast, subjects aged over 40
years had signiﬁcantly greater loss of medial, lateral and total
femoral cartilage volume than subjects under 40 years of age
(Table II). BMIwas not associatedwith loss of femoral cartilage
volume in the whole sample. Smoking status was not associ-
ated with loss of femoral cartilage volume, but years and
pack-years of smoking were signiﬁcantly associated with loss
of medial, lateral and total cartilage volume (Table II). Severe
smoking (pack-years of 20þ) was associated with greater
loss of total femoral cartilage volume compared withI
ge in femoral cartilage volume
b (95% CI) (% pa) P-value
Multivariable*
.08) L1.35 (L2.18, L0.52) 0.002
0.002) 0.04 (0.09, þ0.02) 0.166
0.29) L1.04 (L1.85, L0.22) 0.013
.09) þ0.02 (0.05, þ0.10) 0.563
.06) 0.58 (1.25, þ0.09) 0.090
0.01) L0.04 (0.07, 0.01) 0.005
0.01) L0.04 (0.07, L0.01) 0.003
.02) L1.76 (L2.63, L0.89) <0.001
.002) L0.05 (L0.10, L0.001) 0.045
0.19) L0.91 (L1.66, L0.16) 0.018
.09) þ0.03 (0.04, þ0.10) 0.377
.34) 0.31 (0.94, þ0.32) 0.338
0.003) L0.03 (L0.05, 0) 0.05
0.01) L0.03 (L0.06, L0.01) 0.012
0.02) L1.69 (L2.52, L0.85) <0.001
0.003) L0.05 (L0.09, L0) 0.05
0.29) L0.96 (L1.70, L0.23) 0.011
.09) þ0.03 (0.04, þ0.09) 0.435
.16) 0.44 (1.05, þ0.17) 0.160
0.01) L0.03 (L0.06, L0.01) 0.015
0.01) L0.04 (L0.06, L0.01) 0.004
d factors including gender, age, BMI, and/or pack-years of smoking.
446 C. Ding et al.: Change in femoral cartilage volumenon-smoking (4.4% vs3.1%,P¼ 0.007). The associations
betweenage, smoking and change in femoral cartilage volume
remained unchanged after adjustment for lower limb muscle
strength.
Baseline lower limb muscle strength was signiﬁcantly as-
sociated with medial (r¼þ0.14, P¼ 0.03) and lateral
(r¼þ0.19, P¼ 0.002) femoral cartilage volume, changes
in both medial and lateral femoral cartilage volume
(Fig. 1) and change in total femoral cartilage volume
(r¼þ0.32, P< 0.001). Subjects in the lowest (weakest)
quartile of baseline lower limb muscle strength had greater50 100 150 200 250
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Fig. 1. Associations between baseline lower limb muscle strength
and annual femoral cartilage volume change. Baseline muscle
strength was positively associated with change in medial (A) and
lateral (B) femoral cartilage volume in total sample, or females
and males separately. Data points, P and r values are presented
after adjustment for age, gender, OA family history, baseline carti-
lage volume, and ROA from the regression models and adding
these to mean cartilage volume change or lower limb muscle
strength.loss of medial and lateral femoral cartilage volume than did
subjects in the highest (strongest) quartile of baseline lower
limb muscle strength (4.1% vs 2.8%, P¼ 0.004 for total
femoral cartilage). Change in lower limb muscle strength as
a continuous variable was not associated with change in
femoral cartilage volume; however, quartiles of percentage
change in lower limb muscle strength were signiﬁcantly as-
sociated with change in medial (b¼þ0.37% per quartile,
P¼ 0.03), lateral (b¼þ0.32% per quartile, P¼ 0.04) and
total (b¼þ0.34% per quartile, P¼ 0.023) femoral cartilage
volume in multivariable analysis. We did not ﬁnd any asso-
ciations between muscle strength and the presence of de-
fects (present vs not present: odds ratio (OR)¼ 1.00 per
kg, P¼ 0.83) at baseline, and between muscle strength
and an increase in cartilage defects over 2 years (increase
vs no increase: OR¼ 1.01 per kg, P¼ 0.10).
Baseline femoral cartilage volume was negatively and
baseline femoral cartilage defect score positively associ-
ated with change in femoral cartilage volume in multivari-
able analyses (both P< 0.01) (Table III). Baseline medial
bone area was positively associated with change in medial
(P< 0.01) and total (P< 0.05) femoral cartilage volume; in
contrast, osteophytes in the lateral compartment were neg-
atively associated with change in lateral cartilage volume
(P¼ 0.01) in multivariable analysis (Table III). Change in
femoral cartilage defects was associated with change in
femoral cartilage volume at total (b¼0.8% per unit,
P< 0.01), medial (b¼1.1% per unit, P< 0.01) and lateral
(b¼1.0% per unit, P< 0.01) sites (Fig. 2).
Knee pain, alignment, and past injury at baseline were
not associated with change in femoral cartilage volume at
both medial and lateral sites (data not shown). Results re-
mained largely unchanged if subjects with ROA (15% in
medial and 4% in lateral compartments) were excluded
from analyses (data not shown).Discussion
This longitudinal study is the ﬁrst to document factors
associated with loss of femoral cartilage volume. In this co-
hort, femoral cartilage lost volume at a rate of approximately
6% at both medial and lateral sites over 2 years. Rate of
loss was higher with female gender, advancing age, smok-
ing, weaker lower limb muscles and loss of lower limb
muscle strength. It was also associated with higher baseline
cartilage volume and lateral osteophytes. Interestingly, car-
tilage defect score and medial tibial bone area at baseline
were positively associated with change in femoral cartilage
volume, while increases in femoral cartilage defect scores
were associated with loss of femoral cartilage volume
over time at both medial and lateral sites.
Although some studies showed that femoral cartilage vol-
ume was associated with radiographic joint space
width18,19, others show that the loss of knee cartilage vol-
ume did not correlate well with change in joint space width
over 2 years in subjects with knee OA3,9,19. These ﬁndings
are most likely due to a lesser variability in relation to mea-
surement error in the radiographic measurement over a rel-
atively short period. We did not perform radiographic
measurement in the follow-up of this study as we consid-
ered it to be not sufﬁciently sensitive to accurately evaluate
the change over 2 years in non-OA subjects. However, we
found that the loss of femoral cartilage volume was signiﬁ-
cantly associated with an increase in femoral cartilage de-
fects, suggesting that loss of cartilage volume is related to
early cartilage damage in non-OA subjects.
Table III
Associations between baseline cartilage and bone measurements and annual change in femoral cartilage volume
b (95% CI) (% pa)
Univariable Multivariable* Multivariabley
Medial femoral cartilage change
Femoral cartilage volume (per ml) 0.14 (0.41, þ0.13) L0.41 (L0.74, L0.07) L0.61 (L0.96, L0.26)
Femoral cartilage defect (per grade) D1.51 (D0.82, D2.20) D1.59 (D0.85, D2.32) D1.55 (D0.79, D2.31)
Tibial bone area (per cm2) D0.17 (D0.04, D0.29) D0.23 (D0.03, D0.42) D0.35 (D0.14, D0.56)
Medial joint space narrowing 0.27 (1.26, þ0.72) 0.24 (1.30, þ0.81) 0.48 (1.49, þ0.53)
Medial osteophytes þ0.59 (0.66, þ1.83) þ0.70 (0.64, þ2.03) 0.56 (1.92, þ0.79)
Lateral femoral cartilage change
Femoral cartilage volume (per ml) 0.10 (0.35, þ0.15) L0.58 (L0.93, L0.23) L0.65 (L1.04, L0.25)
Femoral cartilage defect (per grade) D1.17 (0.51, D1.83) D1.26 (D0.57, D1.96) D1.52 (D0.81, D2.23)
Tibial bone area (per cm2) þ0.01 (0.15, þ0.17) 0.18 (0.42, þ0.06) þ0.04 (0.24, þ0.32)
Lateral joint space narrowing 0.09 (1.69, þ1.52) þ0.27 (1.34, þ1.91) þ0.07 (1.53, þ1.66)
Lateral osteophytes 0.57 (1.83, þ0.69) 0.59 (1.86, þ0.67) L1.91 (L3.38, L0.45)
Total femoral cartilage change
Femoral cartilage volume (per ml) 0.06 (0.19, þ0.07) L0.28 (L0.46, L0.10) L0.36 (L0.56, L0.17)
Femoral cartilage defect (per grade) D1.08 (0.70, D1.46) D1.20 (D0.78, D1.61) D1.07 (D0.67, D1.47)
Tibial bone area (per cm2) D0.07 (0.003, D0.14) þ0.06 (0.07, þ0.18) D0.13 (D0.02, D0.25)
Total joint space narrowing þ0.03 (0.66, þ0.71) þ0.16 (0.55, þ0.88) 0.01 (0.07, þ0.06)
Total osteophytes þ0.35 (0.34, þ1.05) þ0.32 (0.40, þ1.04) 0.14 (0.80, þ0.52)
Bold denotes statistically signiﬁcant result.
*Adjusted for factors including age, gender, BMI, OA family history, muscle strength and ROA.
yFurther adjusted for factors listed in the table.
447Osteoarthritis and Cartilage Vol. 16, No. 4Signiﬁcant correlations between change in femoral and in
tibial cartilage volume were previously reported in OA pa-
tients17. However, we found that change in femoral cartilage
volume does not share all risk factors and structural associ-
ations with change in tibial cartilage volume. For example,
OA family history was associated with tibial10 but not femo-
ral cartilage loss. Moreover, baseline cartilage defects and
tibial bone area were negatively associated with change
in tibial13 but positively with change in femoral cartilage
volume. The exact reasons for this difference are unclear
but most likely reﬂect some differences in the pathophysio-
logical progress in the two compartments. Indeed in this
cohort, 21% and 26% of subjects had normal cartilage
with no defects (grade 0) at medial and lateral femoral sites,
respectively, whereas in tibial sites at baseline all subjects
had grade 1 or higher than grade 1 cartilage defects
(Ding et al., personal observation). These ﬁndings indicate
the possibility that cartilage erosion occurs at an earlier
stage on the tibia. The increase in the femoral cartilage vol-
ume is most interesting, and suggests that the presence of
cartilage swelling24 is an early manifestation of OA lesions.
Moreover, our data also suggested that early subchondral
bone expansion may induce femoral cartilage swelling.
Data thus suggest that the cartilage defects were predictive
of an increase in femoral cartilage volume, while higher
baseline cartilage volume and an increase in cartilage de-
fects were associated with higher loss of cartilage volume,
suggesting that the femoral cartilage swelling (reﬂected by
an increased baseline cartilage volume) precedes the
appearance of cartilage erosion and volume loss in a pro-
portion of subjects.
It is well established that female gender and age are strong
risk factors for knee OA25. This study conﬁrms the role of
these factors in femoral cartilage loss as well as agrees
with data on tibial plateaus1,2,7,15,20,26, suggesting largely
common risk factors at both femoral and tibial sites. Other
OA risk factors, such as meniscal tears and extrusion21,27,
are also associated with femoral cartilage loss. Our ﬁndings
are most interesting as they point to the fact that these riskfactors are important not only for disease progression but
also for the development of early OA lesions. In contrast,
past knee injury, which is associated with meniscal extru-
sion21, was not associated with loss of femoral cartilage vol-
ume in this study. Similar to the loss of tibial cartilage
volume22, knee malalignment was not associated with loss
of femoral cartilage volume, suggesting knee malalignment
may not play a role in the development of early OA lesions.
There are conﬂicting data regarding the role of cigarette
smoking and limb muscle strength in the pathogenesis of
OA.While somestudies have reported that smoking is not as-
sociated with development of ROA28,29, most suggested that
smoking has a protective effect on prevalent and incident
knee or hipROA30e32.Our data inwhich the severity of smok-
ing was signiﬁcantly associated with loss of both medial and
lateral femoral cartilage volume over 2 years agree with re-
cent reports using MRI which documented that OA men
(but not women) who were current smokers were at a higher
risk for knee cartilage lesion development than non- and ex-
smokers, particularly at the medial tibiofemoral joint and the
patellofemoral joint33, and that smoking had doseeresponse
associations with annual loss of tibial cartilage volume, and
with increases in tibiofemoral cartilage defect scores in
offspring (but not controls)11.
With regard to lower limb muscle, we found that higher
strength was associated with less loss of medial and lat-
eral femoral cartilage volume. More importantly, change in
lower limb muscle strength was positively associated with
change in femoral cartilage volume in this largely non-OA
cohort. This concurs with the data obtained with the tibial
cartilage12, and those on tibiofemoral and patellofemoral
OA34,35, showing that muscle strength has a protective
effect on the onset of the disease. These ﬁndings have
potential practical implications for the prevention of
the development of OA. However, muscle strengthening
may not decrease the risk of disease progression in peo-
ple with already-established knee OA36, or even was as-
sociated with increased likelihood of tibiofemoral OA
progression in malaligned knees and unstable knees37.
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Fig. 2. Box plots of annual femoral cartilage volume change vs the
change in cartilage defect score. The change in femoral cartilage
score at medial (A) and lateral (B) sites was negatively associated
with change in femoral cartilage volume at the corresponding site in
total sample or in females. Boxes represent 25the75th percentiles
[interquartile range (IQR)]; horizontal lines within boxes represent
medians; vertical bars represent 1.5 the IQR. Circles represent
values above or below the 1.5 IQR values. Data points and
P-values are presented after adjustment for age, sex, BMI, OA
family history, baseline cartilage volume, baseline cartilage defect
and ROA from the regression models and adding these to mean
cartilage volume change or cartilage defect change.
448 C. Ding et al.: Change in femoral cartilage volumeOsteophytes were negatively associated with change in
lateral femoral cartilage volume, suggesting that subchon-
dral bone change may eventually lead to femoral cartilage
loss. This is consistent with a previous report showing that
osteophytes were positively associated with increases in ti-
biofemoral cartilage defects over 2 years15. In the future, it
could be interesting to evaluate the correlation between os-
teophyte progression vis-a`-vis femoral cartilage volume
loss at follow-up in such a cohort. Although our study
has a number of potential limitations as extensively dis-
cussed previously7,13,16,38, this longitudinal study provides
most interesting information about the risk factors associ-
ated with early femoral cartilage loss, and potentially effec-
tive measures such as smoking cessation and lower limb
muscle strengthening aiming at protection against cartilage
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